These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18260347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
    Sugaya Y, Ochi M, Hashimoto S, Muraki J, Morita T, Kobayashi Y, Nakamura S, Tokue A.
    Hinyokika Kiyo; 1997 Jul; 43(7):495-9. PubMed ID: 9282296
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Determination of urinary CA19-9 levels in urothelial cancer--assessment of its role in diagnosis].
    Noto K, Fujime M, Isobe H, Wakumato Y, Kawachi Y.
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):406-13. PubMed ID: 9125864
    [Abstract] [Full Text] [Related]

  • 9. [A case of renal pelvic cancer with high serum level of CA 19-9].
    Iwata H, Sugimoto T, Asai T, Kamikawa S, Kim T, Hayahara N, Nakatani T, Yamamoto K, Kishimoto T.
    Hinyokika Kiyo; 1998 Sep; 44(9):653-6. PubMed ID: 9805671
    [Abstract] [Full Text] [Related]

  • 10. [Case with renal pelvic carcinoma with giant hydronephrosis].
    Maruyama T, Kubo M, Shinchou M, Hashimoto T, Mitsui Y, Ueda Y, Suzuki T, Higuchi Y, Qui J, Kondoh N, Nojima M, Yamamoto S, Shima H, Hirota S.
    Hinyokika Kiyo; 2008 Nov; 54(11):727-31. PubMed ID: 19068727
    [Abstract] [Full Text] [Related]

  • 11. [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report].
    Kobori Y, Shigehara K, Amano T, Takemae K.
    Hinyokika Kiyo; 2005 Feb; 51(2):105-8. PubMed ID: 15773363
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A case of CA19-9 producing transitional cell carcinoma of the ureter].
    Yamamoto H, Ueda Y, Maruyama T, Kondou N, Nojima M, Takiuchi H, Mori Y, Shima H, Kubota A.
    Hinyokika Kiyo; 2003 Sep; 49(9):543-5. PubMed ID: 14598694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.
    Yaegashi H, Izumi K, Kadomoto S, Naito R, Makino T, Iwamoto H, Nohara T, Shigehara K, Kadono Y, Mizokami A.
    Anticancer Res; 2019 Jan; 39(1):375-380. PubMed ID: 30591483
    [Abstract] [Full Text] [Related]

  • 18. [A case of urachal carcinoma associated with elevated levels of CA19-9].
    Koyama I, Yamazaki Y, Nakamura R, Yago R, Nakamura M, Kobayashi H, Uchida Y, Ichikawa Y, Toma H.
    Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1587-90. PubMed ID: 7474611
    [Abstract] [Full Text] [Related]

  • 19. Primary mucinous adenocarcinoma of the renal pelvis with elevated CEA and CA19-9.
    Ye YL, Bian J, Huang YP, Guo Y, Li ZX, Deng CH, Dai YP, Sun XZ.
    Urol Int; 2011 Oct; 87(4):484-8. PubMed ID: 21893942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.